D. Armstrong

发表

Diagnostic Accuracy of a Rapid Urine Lipoarabinomannan Test for Tuberculosis in HIV-Infected Adults

S. Dorman, D. Alland, W. Sikhondze, 2014, Journal of acquired immune deficiency syndromes.

Predictors and outcomes of mycobacteremia among HIV-infected smear- negative presumptive tuberculosis patients in Uganda

S. Dorman, J. Ellner, Y. Manabe, 2015, BMC Infectious Diseases.

Sensititre MYCOTB MIC Plate for Testing Mycobacterium tuberculosis Susceptibility to First- and Second-Line Drugs

S. Dorman, D. Alland, Sang-Nae Cho, 2013, Antimicrobial Agents and Chemotherapy.

Prospective Cross-Sectional Evaluation of the Small Membrane Filtration Method for Diagnosis of Pulmonary Tuberculosis

S. Dorman, D. Alland, J. Ellner, 2014, Journal of Clinical Microbiology.

Specimen Dilution Improves Sensitivity of the Amplified Mycobacterium tuberculosis Direct Test for Smear Microscopy-Positive Respiratory Specimens

M. Conde, S. Dorman, D. Armstrong, 2007, Journal of Clinical Microbiology.

Predicting TB treatment outcomes using baseline risk and treatment response markers: developing the PredictTB early treatment completion criteria

L. Dodd, D. Alland, Jill Winter, 2020 .

Current Updates on Mycobacterial Taxonomy, 2018 to 2019

D. Armstrong, N. Parrish, 2021, Journal of clinical microbiology.

Multilocus enzyme electrophoresis analysis of rapidly-growing mycobacteria: an alternative tool for identification and typing.

D. Armstrong, J. Caierão, R. Duarte, 2016, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Multidrug-Resistant Nontuberculous Mycobacteria Isolated from Cystic Fibrosis Patients

F. Mello, M. Lourenço, D. Armstrong, 2014, Journal of Clinical Microbiology.

isolated from cystic fibrosis patients

D. Armstrong, S. Leão, M. Silva, 2014 .

A Phase 2 Randomized Trial of a Rifapentine plus Moxifloxacin-Based Regimen for Treatment of Pulmonary Tuberculosis

K. Dooley, Carla Loredo, A. Efron, 2016, PloS one.

Use of the amplified mycobacterium tuberculosis direct test in a public health laboratory: test performance and impact on clinical care.

S. Dorman, G. Maltas, D. Armstrong, 2007, Chest.

Direct detection of SARS-CoV-2 RNA using high-contrast pH-sensitive dyes

Andrew L. Lemire, W. Korff, J. Grimm, 2021, medRxiv.

Evaluation of a Rapid Molecular Drug‐Susceptibility Test for Tuberculosis

S. Dorman, D. Alland, Sang-Nae Cho, 2017, The New England journal of medicine.

Improving the Sensitivity of the Xpert MTB/RIF Assay on Sputum Pellets by Decreasing the Amount of Added Sample Reagent: a Laboratory and Clinical Evaluation

S. Dorman, D. Alland, J. Ellner, 2015, Journal of Clinical Microbiology.

High Genotypic Discordance of Concurrent Mycobacterium tuberculosis Isolates from Sputum and Blood of HIV-Infected Individuals

F. Cobelens, B. D. de Jong, Y. Manabe, 2015, PloS one.

Multicenter Study of the Accuracy of the BD MAX Multidrug-resistant Tuberculosis Assay for Detection of Mycobacterium tuberculosis Complex and Mutations Associated With Resistance to Rifampin and Isoniazid

Charles K. Cooper, S. Dorman, J. Betz, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Comparative performance of urinary lipoarabinomannan assays and Xpert MTB/RIF in HIV-infected individuals

S. Dorman, J. Ellner, Y. Manabe, 2014, AIDS.

Point-of-care C-reactive protein-based tuberculosis screening for people living with HIV: a diagnostic accuracy study

D. Dowdy, M. Kamya, A. Cattamanchi, 2017, The Lancet. Infectious diseases.

Clinical Validation of the Xpert MTB/RIF Test for Identification of the Mycobacterium tuberculosis Complex in Acid-Fast Bacillus Smear-Positive MGIT Broth Cultures

D. Gnanashanmugam, D. Armstrong, N. Parrish, 2022, Journal of clinical microbiology.

SARS-CoV-2 Supply Shortages and Tuberculosis Diagnostics: Current Issues Requiring Immediate Solutions

G. Olinger, Debanjana Dasgupta, D. Armstrong, 2021, Journal of clinical microbiology.

Yield and Efficiency of Novel Intensified Tuberculosis Case‐Finding Algorithms for People Living with HIV

C. McCulloch, D. Dowdy, M. Kamya, 2019, American journal of respiratory and critical care medicine.

Tuberculosis screening improves preventive therapy uptake (TB SCRIPT) trial among people living with HIV in Uganda: a study protocol of an individual randomized controlled trial

D. Dowdy, M. Kamya, P. Phillips, 2022, Trials.

Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into emergence and spread of multidrug resistance

Thomas Abeel, James E. Galagan, Andrei Gabrielian, 2017, Nature Genetics.

Delayed rise of oral fluid antibodies, elevated BMI, and absence of early fever correlate with longer time to SARS-CoV-2 RNA clearance in an longitudinally sampled cohort of COVID-19 outpatients

S. Klein, R. Ursin, A. Pekosz, 2021, medRxiv.

Repeated Coronavirus Disease 2019 Molecular Testing: Correlation of Severe Acute Respiratory Syndrome Coronavirus 2 Culture With Molecular Assays and Cycle Thresholds

K. Carroll, A. Pekosz, H. Mostafa, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Repeated Coronavirus Disease 2019 Molecular Testing: Correlation of Severe Acute Respiratory Syndrome Coronavirus 2 Culture With Molecular Assays and Cycle Thresholds

K. Carroll, A. Pekosz, H. Mostafa, 2020, Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America.

Repeat COVID-19 Molecular Testing: Correlation with Recovery of Infectious Virus, Molecular Assay Cycle Thresholds, and Analytical Sensitivity

K. Carroll, A. Pekosz, H. Mostafa, 2020, medRxiv.

Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study

S. Dorman, D. Alland, S. Chakravorty, 2018, The Lancet. Infectious diseases.

Delayed Rise of Oral Fluid Antibodies, Elevated BMI, and Absence of Early Fever Correlate With Longer Time to SARS-CoV-2 RNA Clearance in a Longitudinally Sampled Cohort of COVID-19 Outpatients

S. Klein, R. Ursin, A. Pekosz, 2021, Open forum infectious diseases.

Clinical Utility of a Novel Molecular Assay in Various Combination Strategies with Existing Methods for Diagnosis of HIV-Related Tuberculosis in Uganda

S. Dorman, F. Cobelens, D. Alland, 2014, PloS one.

Cost-Effectiveness of Different Strategies for Amplified Mycobacterium tuberculosis Direct Testing for Cases of Pulmonary Tuberculosis

M. Conde, S. Dorman, D. Armstrong, 2008, Journal of Clinical Microbiology.

Analytical and Clinical Evaluation of the Epistem Genedrive Assay for Detection of Mycobacterium tuberculosis

S. Dorman, D. Alland, P. Banada, 2016, Journal of Clinical Microbiology.

Viral suppression among adults with HIV receiving routine dolutegravir-based antiretroviral therapy and 3 months weekly isoniazid-rifapentine

D. Dowdy, M. Kamya, D. Armstrong, 2023, AIDS.

A Brief Update on Mycobacterial Taxonomy, 2020 to 2022

D. Armstrong, N. Parrish, Emma Eisemann, 2023, Journal of Clinical Microbiology.

Multidrug-Resistant Nontuberculous Mycobacteria Isolated from Cystic Fibrosis Patients

F. Mello, M. Lourenço, D. Armstrong, 2014, Journal of Clinical Microbiology.

Repeat COVID-19 Molecular Testing: Correlation of SARS-CoV-2 Culture with Molecular Assays and Cycle Thresholds

K. Carroll, A. Pekosz, H. Mostafa, 2020 .